Hjortso, E., J.Qvist, M.I.Bud, J.L.Thomsen, J.B.Andersen, F.Wiberg-Jorgensen, N.K.Jensen, R.Jones, L.M.Reid, and W.M.Zapol. 1988. ARDS after accidental inhalation of zinc chloride smoke. Intensive Care Med. 14(1): 17–24.

IPCS (International Programme on Chemical Safety). 1998. Environmental Health Criteria 204: Boron. Geneva: World Health Organization.

Jansen, J.A., J.S.Schou, and A.Aggerbeck. 1984. Gastro-intestinal absorption and in vitro release of boric acid from water-emulsifying ointments. Food Chem. Toxicol. 22(1):49–53.

Jenkins, R.O., P.J.Craig, W.Goessler, and K.J.Irgolic. 1998. Antimony leaching from cot mattresses and sudden infant death syndrome (SIDS). Hum. Exp. Toxicol. 17(3):138–139.

Keen, C.L., and L.S.Hurley. 1977. Zinc absorption through skin: correction of zinc deficiency in the rat. Am. J. Clin. Nutr. 30(4):528–530.

Kent, N.L., and R.A.McCance. 1941. The absorption and excretion of minor elements in man: silver, gold, lithium, boron, vanadium. Biochem. J. 35:837–844.

Kowalska-Wochna, E.J.Moniuszko-Jakoniuk, E.Kulikowska, et al. 1988. The effect of orally applied aqueous solutions of lead and zinc on chromosome aberrations and induction of sister chromatid exchanges in the rat (Rattus sp.) Genetica Polonica 29(2):181–189.

Kozik, M.B., L.Maziarz, and A.Godlewski. 1980. Morphological and histochemical changes occurring in the brain of rats fed large doses of zinc oxide. Folia Histochem. Cytochem. 18:201–206.

Kozik, M.B., G.Gramza, and M.Pietrzak. 1981. Neurosecretion of the hypothalamohypophyseal system after intragastric administration of zinc oxide. Folia Histochem. Cytochem. (Krakow). 19(2):115–122.

Krasovskii, G.N., S.P.Varshavskaya, and A.I.Borisov. 1976. Toxic and gonadotropic effects of cadmium and boron relative to standards for these substances in drinking water. Environ. Health Perpect. 13:69–75.

Ku, W.W., R.E.Chapin, R.F.Moseman, R.E.Brink, K.D.Pierce, and K.Y.Adams. 1991. Tissue disposition of boron in Fischer rats. Toxicol. Appl. Pharmacol. 111(1):145–151.

Ku, W.W., R.E.Chapin, R.N.Wine, and B.C.Gladen. 1993. Testicular toxicity of boric acid (BA): Relationship of dose to lesion development and recovery in the F344 rat. Reprod. Toxicol. 7(4):305–319.

Kuschner, W.G., A.D’Alessandro, S.F.Wintermeyer, H.Wong, H.A.Boushey, and P.D. Blanc. 1995. Pulmonary responses to purified zinc oxide fume. J. Investig. Med. 43(4):371–378.

Kuschner, W.G., A.D’Alessandro, H.Wong, and P.D.Blanc. 1997. Early pulmonary cytokine responses to zinc oxide fume inhalation. Environ. Res. 75(1):7–11.

Kynast, G., and E.Saling. 1986. Effect of oral zinc application during pregnancy. Gynecol. Obstet. Invest. 21(3): 117–123.

Lam, H.F., R.Peisch, and M.O.Amdur. 1982. Changes in lung volumes and diffusing capacity in guinea pigs exposed to a combination of sulfur dioxide and submicron zinc oxide mixed in a humidified furnace. Toxicol. Appl. Pharmacol. 66(3):427–433.

Lam, H.F., M.W.Conner, A.E.Rogers, S.Fitzgerald, and M.O.Amdur. 1985. Func-

Front Matter (R1-R22)

Executive Summary (1-14)

1 Introduction (15-20)

2 Assessment of Health Risks from the Use of Flame Retardants (21-34)

3 Exposure Assessment Methodology (35-52)

4 Hexabromocyclododecane (53-71)

5 Decabromodiphenyl Oxide (72-98)

6 Alumina Trihydrate (99-130)

7 Magnesium Hydroxide (131-148)

8 Zinc Borate (149-191)

9 Calcium and Zinc Molybdates (192-228)

10 Antimony Trioxide (229-261)

11 Antimony Pentoxide and Sodium Antimonate (262-272)

12 Ammonium Polyphosphates (273-290)

13 Phosphonic Acid, (3-{[Hydroxymethyl]amino}-3-Oxopropyl)-Dimethyl Ester (291-306)

14 Organic Phosphonates (307-337)

15 Tris Monochloropropyl Phosphates (338-357)

16 Tris (1,3-dichloropropyl-2) Phosphate (358-386)

17 Aromatic Phosphate Plasticizers (387-416)

18 Tetrakis(hydroxymethyl) Phosphonium Salts (417-439)

19 Chlorinated Paraffins (440-492)

Appendix A Biographical Sketches (493-498)

Appendix B Flame-Retardant Composition in Fabrics: Their Durability and Permanence (499-512)